AU3569678A - Benzimidazole derivatives - Google Patents

Benzimidazole derivatives

Info

Publication number
AU3569678A
AU3569678A AU35696/78A AU3569678A AU3569678A AU 3569678 A AU3569678 A AU 3569678A AU 35696/78 A AU35696/78 A AU 35696/78A AU 3569678 A AU3569678 A AU 3569678A AU 3569678 A AU3569678 A AU 3569678A
Authority
AU
Australia
Prior art keywords
benzimidazole derivatives
benzimidazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU35696/78A
Other languages
English (en)
Inventor
Roger Edward Markwell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB18438/77A external-priority patent/GB1595316A/en
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU3569678A publication Critical patent/AU3569678A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU35696/78A 1977-05-03 1978-05-03 Benzimidazole derivatives Pending AU3569678A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB18438/77A GB1595316A (en) 1977-05-03 1977-05-03 4-(3-amino-2-hydroxy-propoxy)-benzimidazole derivatives and pharmaceutical compositions containing them
GB4915677 1977-11-25
GB220878 1978-01-19

Publications (1)

Publication Number Publication Date
AU3569678A true AU3569678A (en) 1979-11-08

Family

ID=27254036

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35696/78A Pending AU3569678A (en) 1977-05-03 1978-05-03 Benzimidazole derivatives

Country Status (18)

Country Link
JP (1) JPS53135979A (it)
AR (2) AR220335A1 (it)
AU (1) AU3569678A (it)
DE (1) DE2819458A1 (it)
DK (1) DK190378A (it)
ES (1) ES469353A1 (it)
FI (1) FI781349A (it)
FR (1) FR2399414A1 (it)
GR (1) GR73669B (it)
IL (1) IL54591A0 (it)
IT (1) IT1096276B (it)
LU (1) LU79591A1 (it)
MC (1) MC1192A1 (it)
NL (1) NL7804794A (it)
NO (1) NO781556L (it)
NZ (1) NZ187066A (it)
PT (1) PT67980A (it)
SE (1) SE7805140L (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2801980A1 (de) * 1978-01-18 1979-07-19 Boehringer Mannheim Gmbh 4-hydroxy-2-benzimidazolin-thion- derivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
EP0003758A1 (de) * 1978-02-09 1979-09-05 Ciba-Geigy Ag Verätherte Hydroxy-benzodiheterocyclen und ihre Säureadditionssalze, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE2905877A1 (de) * 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CH661501A5 (fr) * 1982-01-26 1987-07-31 Oreal Composes derivant du amino-3 propanol-2 utilisables pour la teinture des cheveux, leur procede de preparation, composition de teinture les contenant et procede de teinture de cheveux correspondant.
DE3839743A1 (de) * 1988-11-25 1990-05-31 Hoechst Ag Verfahren zur herstellung von benzimidazolonen
US9784726B2 (en) 2013-01-08 2017-10-10 Atrogi Ab Screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1058822A (en) * 1963-07-30 1967-02-15 Ici Ltd 3-amino-2-hydroxypropoxy heterocyclic derivatives
CH559729A5 (it) * 1970-10-23 1975-03-14 Hoechst Ag
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
CH624395A5 (it) * 1976-01-08 1981-07-31 Ciba Geigy Ag

Also Published As

Publication number Publication date
MC1192A1 (fr) 1979-02-23
FR2399414A1 (fr) 1979-03-02
AR219173A1 (es) 1980-07-31
GR73669B (it) 1984-03-28
IT1096276B (it) 1985-08-26
SE7805140L (sv) 1978-11-04
NO781556L (no) 1978-11-06
IL54591A0 (en) 1978-07-31
JPS53135979A (en) 1978-11-28
NL7804794A (nl) 1978-11-07
FI781349A (fi) 1978-11-04
PT67980B (it) 1980-05-05
PT67980A (en) 1978-06-01
NZ187066A (en) 1981-02-11
IT7823000A0 (it) 1978-05-03
AR220335A1 (es) 1980-10-31
DE2819458A1 (de) 1978-11-16
DK190378A (da) 1978-11-04
ES469353A1 (es) 1980-01-01
LU79591A1 (de) 1979-06-13

Similar Documents

Publication Publication Date Title
IL55387A0 (en) Triphenylalkene derivatives
AU4113878A (en) 1-alkanoyl-proline derivatives
GB2003876B (en) Beta-haloethylamine derivatives
NZ186175A (en) Meta-sulphonamidobenzamide derivatives
AU3569678A (en) Benzimidazole derivatives
EG13665A (en) 2-imino-imidazolidine derivatives
AU3888578A (en) 4-hydroxy-2-benzimidazolinone derivatives
GB2009180B (en) 25-alkylcholestrerol derivatives
GB2009150B (en) Tetrahydrophtalamide derivatives
MY8400370A (en) Prostanol derivatives
GB2005261B (en) 2-oxazolydone derivatives
PH13915A (en) Chinazoline derivatives
IL56042A0 (en) Prostanglandin derivatives
GB2014131B (en) 1-hydrocarbylpyrrole derivatives
GB2003479B (en) 3-amino-17alpha-aza-d-homoandrostane derivatives
NZ188863A (en) 2-oxo-hexahydroazepine -piperidine and -pyrrolidine derivatives
AU3313978A (en) Everninomicin derivatives
GB2000128B (en) 15-substituted-omega-pentanorprostaglandin derivatives
GB2000769B (en) 4 - homoisotwistane derivatives
JPS5470273A (en) Benzimidazole derivative
GB2008119B (en) Arylsteroid derivatives
AU4129978A (en) Eburnamenine derivatives
IL54973A0 (en) 3-pyridylhydroxy-prop-1-ene derivatives
GB2060630B (en) Pyrazinoquinoline derivatives
ZA782377B (en) Benzimidazole derivatives